10 November 2017
SpeeDx is transforming global health outcomes
SpeeDx has significantly contributed to the success and development of the Australian MedTech industry. The CSIRO’s Medical Technologies and Pharmaceutical...
8 November 2017
Elisa Mokany – winner of the “Outstanding Achievement” Medtech Industry award
We are happy to announce our Chief Technology Officer, Elisa Mokany, has won the "Outstanding Achievement" award at the Medical...
26 October 2017
PlexPCR® VHS | HSV-1&2, VZV TP | Receives CE-Marking
SpeeDx Multiplexed VZV, Herpes, Syphilis Assay Receives CE-IVD Mark SpeeDx Pty. Ltd. has announced that it has received CE-IVD marking for...
25 October 2017
True Leaders Game Changers 2017 – Alison Todd
SpeeDx's Alison Todd frontline fighter in the war on superbugs Alison Todd co-founded SpeeDx with Elisa Mokany in 2008. The company...
25 September 2017
Mycoplasma genitalium macrolide resistance in QLD
The macrolide azithromycin is recommended for treatment of Mycoplasma genitalium infection; however, M. genitalium strains possessing macrolide resistance-mediating mutations (MRMMs)...
19 September 2017
SpeeDx and Diagen sign new distribution agreement for Scandinavia
SpeeDx Pty, Ltd. has announced a distribution agreement with Diagen, a leading Scandinavian clinical laboratory supplier specialising in diagnostic products....
